{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:45:26Z","timestamp":1790858726328,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":411,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ijcard.2011.06.064","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T07:52:46Z","timestamp":1309852366000},"page":"64-69","source":"Crossref","is-referenced-by-count":54,"title":["Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease"],"prefix":"10.1016","volume":"164","author":[{"given":"Jeroen C.","family":"Vis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle G.","family":"Duffels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepijn","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne H.A.C.M.","family":"de Bruin-Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berto J.","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf M.F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke S.","family":"Hoendermis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie P.J.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2011.06.064_bb0005","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0010","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/euhj.1998.1046","article-title":"Eisenmenger syndrome. Factors relating to deterioration and death","volume":"19","author":"Daliento","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0015","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/hrt.2006.098848","article-title":"Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease","volume":"93","author":"Engelfriet","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","article-title":"Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry","volume":"120","author":"Duffels","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.healun.2006.11.009","article-title":"Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan","volume":"26","author":"Keogh","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1183\/09031936.04.00122204","article-title":"End points in pulmonary arterial hypertension: the way forward","volume":"23","author":"Peacock","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/hrt.2006.097360","article-title":"Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect","volume":"93","author":"D'Alto","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0050","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/hrt.2006.089185","article-title":"Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease","volume":"93","author":"Diller","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1747-0803.2007.00104.x","article-title":"Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition","volume":"2","author":"Duffels","year":"2007","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0060","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ahj.2005.07.005","article-title":"Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy","volume":"150","author":"Schulze-Neick","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0065","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/thx.2005.040618","article-title":"Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol","volume":"60","author":"Sitbon","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2006.100388","article-title":"Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study","volume":"93","author":"Apostolopoulou","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0075","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2009.01.021","article-title":"Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome","volume":"103","author":"Duffels","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0080","first-page":"359","article-title":"Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan","volume":"6","author":"Schuuring","year":"2010","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0085","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","article-title":"Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?","volume":"154","author":"van Loon","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2008.02.025","article-title":"Down patients with Eisenmenger syndrome: is bosentan treatment an option?","volume":"134","author":"Duffels","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"Guidelines for the six-minute walk test","volume":"166","author":"American Thoracic Society statement","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0100","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.apmr.2009.02.015","article-title":"Six-minute walk test in patients with Down syndrome: validity and reproducibility","volume":"90","author":"Vis","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study","volume":"127","author":"Gatzoulis","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","article-title":"The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension","volume":"15","author":"McKenna","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.rmed.2008.04.016","article-title":"Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension","volume":"102","author":"Zlupko","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2788.2009.01158.x","article-title":"Down syndrome: a cardiovascular perspective","volume":"53","author":"Vis","year":"2009","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1378\/chest.125.2.572","article-title":"Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension","volume":"125","author":"Roeleveld","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1378\/chest.10-1066","article-title":"Clinical significant change of stroke volume in pulmonary hypertension","volume":"139","author":"van Wolferen","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0135","first-page":"100","article-title":"Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome","volume":"15","author":"Hopkins","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0145","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1532-5415.2008.01999.x","article-title":"Survival in elderly persons with Down syndrome","volume":"56","author":"Coppus","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ijcard.2011.06.064_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2009.04.037","article-title":"Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis","volume":"144","author":"Berger","year":"2010","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311006048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311006048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T18:23:49Z","timestamp":1543688629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527311006048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0167527311006048"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.06.064","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}